发明申请
US20140088027A1 PHARMACEUTICAL COMPOSITION COMPRISING AN SGLT2 INHIBITOR AND A PPAR- GAMMA AGONIST AND USES THEREOF
审中-公开
包含SGLT2抑制剂和PPAR-GAMMA AGONIST的药物组合物及其用途
- 专利标题： PHARMACEUTICAL COMPOSITION COMPRISING AN SGLT2 INHIBITOR AND A PPAR- GAMMA AGONIST AND USES THEREOF
- 专利标题（中）： 包含SGLT2抑制剂和PPAR-GAMMA AGONIST的药物组合物及其用途
-
申请号： US13637413申请日： 2011-03-28
-
公开(公告)号： US20140088027A1公开(公告)日： 2014-03-27
- 发明人: Rolf Grempler , Thomas Klein , Michael Mark , Leo Seman , Leo Thomas
- 申请人： Rolf Grempler , Thomas Klein , Michael Mark , Leo Seman , Leo Thomas
- 申请人地址： DE Ingelheim am Rhein
- 专利权人： BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- 当前专利权人： BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- 当前专利权人地址： DE Ingelheim am Rhein
- 国际申请： PCT/EP2011/054734 WO 20110328
- 主分类号： A61K31/7048
- IPC分类号： A61K31/7048 ; A61K31/4439
摘要：
The invention relates to a pharmaceutical composition comprising an SGLT2 inhibitor and a PPARγ agonist which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
信息查询
